BIRD - Belgian Inflammatory Bowel Disease Research and Development

The Belgian Inflammatory Bowel Disease Research and Development Group (BIRD) is to stimulate research in the field of Inflammatory Bowel disease (IBD). The BIRD group furthermore wants to improve clinical and scientific knowledge about the disease between gastroenterologists. By performing original epidemiological and clinical studies, we want to be at the forefront of improving existing therapies, and providing the best care to IBD patients. We want to advance the current understanding on the pathogenesis of the disease and we have a strong commitment to support young clinicians and/or researchers through scientific grants

Bird - belgian inflammatory bowel disease research and development operates in the Research services industry.

Bird - belgian inflammatory bowel disease research and development's revenue is 11m - 100m

Bird - belgian inflammatory bowel disease research and development has 11 - 50 employees.